213 related articles for article (PubMed ID: 6806416)
61. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
[TBL] [Abstract][Full Text] [Related]
62. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
[TBL] [Abstract][Full Text] [Related]
63. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
64. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
65. The effects of bromocriptine, thyrotropin-releasing hormone, and gonadotropin-releasing hormone on hormone secretion by gonadotropin-secreting pituitary adenomas in vivo and in vitro.
Lamberts SW; Verleun T; Oosterom R; Hofland L; van Ginkel LA; Loeber JG; van Vroonhoven CC; Stefanko SZ; de Jong FH
J Clin Endocrinol Metab; 1987 Mar; 64(3):524-30. PubMed ID: 3102540
[TBL] [Abstract][Full Text] [Related]
66. Gonadotropin-releasing hormone-induced partial empty sella clinically mimicking pituitary apoplexy in a woman with a suspected non-secreting macroadenoma.
Foppiani L; Piredda S; Guido R; Spaziante R; Giusti M
J Endocrinol Invest; 2000 Feb; 23(2):118-21. PubMed ID: 10800766
[TBL] [Abstract][Full Text] [Related]
67. Effects of naloxone on prolactin-secreting pituitary adenomas.
Shima K; Chigasaki H; Seki K
Neurol Med Chir (Tokyo); 1990 Feb; 30(2):109-12. PubMed ID: 1695330
[TBL] [Abstract][Full Text] [Related]
68. [The combined stimulation test sulpiride-TRH in the investigation of prolactin secretion].
Miras-Mirakian P; Claustrat F; Dechaud H; Pugeat M
J Gynecol Obstet Biol Reprod (Paris); 1992; 21(4):419-23. PubMed ID: 1624729
[TBL] [Abstract][Full Text] [Related]
69. Regression of a pituitary adenoma following levothyroxine therapy of primary hypothyroidism.
Valenta LJ; Tamkin J; Sostrin R; Elias AN; Eisenberg H
Fertil Steril; 1983 Sep; 40(3):389-92. PubMed ID: 6411499
[TBL] [Abstract][Full Text] [Related]
70. Chromogranin A as serum marker of pituitary adenomas.
Gussi IL; Young J; Baudin E; Bidart JM; Chanson P
Clin Endocrinol (Oxf); 2003 Nov; 59(5):644-8. PubMed ID: 14616890
[TBL] [Abstract][Full Text] [Related]
71. Long-term bromocriptine therapy may restore the inhibitory control of prolactin release in some patients with pathological hyperprolactinemia.
Ho KY; Smythe GA; Compton PJ; Lazarus L
Aust N Z J Med; 1985 Apr; 15(2):213-9. PubMed ID: 3927887
[TBL] [Abstract][Full Text] [Related]
72. The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
Ayalon D; Persitz E; Ravid R; Jedwab G; Avidan S; Cordova T; Harell A
Clin Endocrinol (Oxf); 1979; 11(2):201-15. PubMed ID: 114343
[TBL] [Abstract][Full Text] [Related]
73. [Release of thyrotropin releasing hormone (TRH) from human prolactin-secreting pituitary adenoma cells. Modulation by dopamine].
Le Dafniet M; Blumberg-Tick J; Yuan Li J; Brandi AM; Bression D; Barret A; Feinstein MC; Peillon F
C R Acad Sci III; 1988; 306(3):129-34. PubMed ID: 3126991
[TBL] [Abstract][Full Text] [Related]
74. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
Barbarino A; De Marinis L; Anile C; Menini E; Merlini G; Maira G
Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
[TBL] [Abstract][Full Text] [Related]
75. Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
Hanew K; Sasaki A; Sato S; Kasai M; Murata K; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1983 Jul; 140(3):225-33. PubMed ID: 6414103
[TBL] [Abstract][Full Text] [Related]
76. Gradual recovery of lactotroph responsiveness to dynamic stimulation following surgical removal of prolactinomas: long-term follow-up studies.
Arafah BM; Brodkey JS; Pearson OH
Metabolism; 1986 Oct; 35(10):905-12. PubMed ID: 3093797
[TBL] [Abstract][Full Text] [Related]
77. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
78. Low recurrence rate after partial hypophysectomy for prolactinoma: the predictive value of dynamic prolactin function tests.
Webster J; Page MD; Bevan JS; Richards SH; Douglas-Jones AG; Scanlon MF
Clin Endocrinol (Oxf); 1992 Jan; 36(1):35-44. PubMed ID: 1559298
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas.
Kageyama K; Sakihara S; Kameda W; Sugiyama A; Takayasu S; Terui K; Daimon M
Endocr J; 2018 Oct; 65(10):1049-1054. PubMed ID: 29973439
[TBL] [Abstract][Full Text] [Related]
80. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma.
Brismar K; Hulting AL; Werner S
J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
